Mitogen-activated protein kinase-activated protein kinase 2 in neuroinflammation, heat shock protein 27 phosphorylation, and cell cycle: Role and targeting fadi maged shokry gurgis

Molecular Pharmacology

Volumn 85, Issue 2, 2014, Pages 345-356

  Ziaziaris, William ^a   Munoz, Lenka ^a  

^a University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CHECKPOINT KINASE 1; CYCLOOXYGENASE 2; HEAT SHOCK PROTEIN 27; INTERLEUKIN 1BETA; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE ACTIVATED PROTEIN KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE D; PROTEIN P53; SMALL INTERFERING RNA; TEMOZOLOMIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

BRAIN; CELL CYCLE; CELL CYCLE CHECKPOINT; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL MIGRATION; DNA DAMAGE; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; GENOMIC INSTABILITY; GLIOBLASTOMA; HUMAN; M PHASE CELL CYCLE CHECKPOINT; NERVOUS SYSTEM INFLAMMATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84891855570     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.113.090365     Document Type: Review

References (145)

1. Abraham RT (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 15:2177-2196
2. Ahn JY, Schwarz JK, Piwnica-Worms H, and Canman CE (2000) Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res 60:5934-5936
3. Alam R, Schultz CR, Golembieski WA, Poisson LM, and Rempel SA (2013) PTEN suppresses SPARC-induced pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma. Neuro-oncol 15:451-461
4. Alford KA, Glennie S, Turrell BR, Rawlinson L, Saklatvala J, and Dean JLE (2007) Heat shock protein 27 functions in inflammatory gene expression and transforming growth factor-b-activated kinase-1 (TAK1)-mediated signaling. J Biol Chem 282: 6232-6241
5. Ancrile B, Lim K-H, and Counter CM (2007) Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev 21:1714-1719
6. Anderson DR, Meyers MJ, Kurumbail RG, Caspers N, Poda GI, Long SA, Pierce BS, Mahoney MW, and Mourey RJ (2009) Benzothiophene inhibitors of MK2 Part 1: structure-activity relationships, assessments of selectivity and cellular potency. Bioorg Med Chem Lett 19:4878-4881
7. Anderson DR, Meyers MJ, Vernier WF, Mahoney MW, Kurumbail RG, Caspers N, Poda GI, Schindler JF, Reitz DB, and Mourey RJ (2007) Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). J Med Chem 50:2647-2654
8. Bachstetter AD, Xing B, de Almeida L, Dimayuga ER, Watterson DM, and Van Eldik LJ (2011) Microglial p38a MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Ab). J Neuroinflammation 8:79
9. Bakkenist CJ and Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:499-506
10. Barr FA, Silljé HH, and Nigg EA (2004) Polo-like kinases and the orchestration of cell division. Nat Rev Mol Cell Biol 5:429-440
11. Ben-Levy R, Hooper S, Wilson R, Paterson HF, and Marshall CJ (1998) Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2 Curr Biol 8:1049-1057
12. Ben-Levy R, Leighton IA, Doza YN, Attwood P, Morrice N, Marshall CJ, and Cohen P (1995) Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2 EMBO J 14:5920-5930
13. Berg BM, Godbout JP, Chen J, Kelley KW, and Johnson RW (2005) alpha-Tocopherol and selenium facilitate recovery from lipopolysaccharide- induced sickness in aged mice. J Nutr 135:1157-1163
14. Brooks K, Oakes V, Edwards B, Ranall M, Leo P, Pavey S, Pinder A, Beamish H, Mukhopadhyay P, and Lambie D et al. (2013) A potent Chk1 inhibitor is selectively cytotoxic in melanomas with high levels of replicative stress. Oncogene 32:788-796
15. Bu Y, Yang Z, Li Q, and Song F (2008) Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells. Oncology 74:198-206
16. Bulavin DV, Higashimoto Y, Popoff IJ, Gaarde WA, Basrur V, Potapova O, Appella E, and Fornace AJ, Jr (2001) Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 411:102-107
17. Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E, and Fornace AJ, Jr (1999) Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J 18:6845-6854
18. Cargnello M and Roux PP (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75:50-83
19. Castro GN, Cayado-Gutiérrez N, Moncalero VL, Lima P, De Angelis RL, Chávez V, Cuello-Carrión FD, and Ciocca DR (2012) Hsp27 (HSPB1): a possible surrogate molecular marker for loss of heterozygosity (LOH) of chromosome 1p in oligodendrogliomas but not in astrocytomas. Cell Stress Chaperones 17:779-790
20. Chang E, Heo K-S, Woo C-H, Lee H, Le N-T, Thomas TN, Fujiwara K, and Abe J-i (2011) MK2 SUMOylation regulates actin filament remodeling and subsequent migration in endothelial cells by inhibiting MK2 kinase and HSP27 phosphorylation. Blood 117:2527-2537
21. Chaturvedi P, Eng WK, Zhu Y, Mattern MR, Mishra R, Hurle MR, Zhang X, Annan RS, Lu Q, and Faucette LF et al. (1999) Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 18:4047-4054
22. Chehab NH, Malikzay A, Appel M, and Halazonetis TD (2000) Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53 Genes Dev 14:278-288
23. Chen F, Wang M, O'Connor JP, He M, Tripathi T, and Harrison LE (2003) Phosphorylation of PPARgamma via active ERK1/2 leads to its physical association with p65 and inhibition of NF-kb. J Cell Biochem 90:732-744
24. Chen G, Hitomi M, Han J, and Stacey DW (2000) The p38 pathway provides negative feedback for Ras proliferative signaling. J Biol Chem 275:38973-38980
25. Cheng R, Felicetti B, Palan S, Toogood-Johnson I, Scheich C, Barker J, Whittaker M, and Hesterkamp T (2010) High-resolution crystal structure of human Mapkap kinase 3 in complex with a high affinity ligand. Protein Sci 19:168-173
26. Chrestensen CA, Schroeder MJ, Shabanowitz J, Hunt DF, Pelo JW, Worthington MT, and Sturgill TW (2004) MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J Biol Chem 279: 10176-10184
27. Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, Fordham M, Neoptolemos JP, Ke Y, and Foster CS (2000) Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res 60:7099-7105
28. Crowe J, Aubareda A, McNamee K, Przybycien PM, Lu X, Williams RO, Bou-Gharios G, Saklatvala J, and Dean JLE (2013) Heat shock protein b1-deficient mice display impaired wound healing. PLoS ONE 8:e77383
29. Culbert AA, Skaper SD, Howlett DR, Evans NA, Facci L, Soden PE, Seymour ZM, Guillot F, Gaestel M, and Richardson JC (2006) MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease. J Biol Chem 281:23658-23667
30. Deleault KM, Skinner SJ, and Brooks SA (2008) Tristetraprolin regulates TNF TNFa mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways. Mol Immunol 45:13-24
31. Dmitrieva NI, Bulavin DV, Fornace AJ, Jr, and Burg MB (2002) Rapid activation of G2/M checkpoint after hypertonic stress in renal inner medullary epithelial (IME) cells is protective and requires p38 kinase. Proc Natl Acad Sci USA 99:184-189
32. Donzelli M and Draetta GF (2003) Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep 4:671-677
33. Ehlting C, Ronkina N, Böhmer O, Albrecht U, Bode KA, Lang KS, Kotlyarov A, Radzioch D, Gaestel M, and Häussinger D et al. (2011) Distinct functions of the mitogen-activated protein kinase-activated protein (MAPKAP) kinases MK2 and MK3: MK2 mediates lipopolysaccharide-induced signal transducers and activators of transcription 3 (STAT3) activation by preventing negative regulatory effects of MK3 J Biol Chem 286:24113-24124
34. Eich M, Roos WP, Nikolova T, and Kaina B (2013) Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide. Mol Cancer Ther 12:2529-2540
35. Engel K, Kotlyarov A, and Gaestel M (1998) Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation. EMBO J 17:3363-3371
36. Falck J, Coates J, and Jackson SP (2005) Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434:605-611
37. Falck J, Mailand N, Syljuasen RG, Bartek J, and Lukas J (2001) The ATM-Chk2- Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410:842-847
38. Fan L, Yang X, Du J, Marshall M, Blanchard K, and Ye X (2005) A novel role of p38 alpha MAPK in mitotic progression independent of its kinase activity. Cell Cycle 4: 1616-1624
39. Ferrao PT, Bukczynska EP, Johnstone RW, and McArthur GA (2012) Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells. Oncogene 31:1661-1672
40. Foster CS, Dodson AR, Ambroisine L, Fisher G, Møller H, Clark J, Attard G, De-Bono J, Scardino P, and Reuter VE et al. (2009) Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement. Br J Cancer 101:1137-1144
41. Fridman JS and Lowe SW (2003) Control of apoptosis by p53 Oncogene 22:9030-9040
42. Furnari B, Rhind N, and Russell P (1997) Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science 277:1495-1497
43. Gaestel M (2006) MAPKAP kinases-MKs-two's company, three's a crowd. Nat Rev Mol Cell Biol 7:120-130
44. Gaestel M (2013) What goes up must come down: molecular basis of MAPKAP kinase 2/3-dependent regulation of the inflammatory response and its inhibition. Biol Chem 394:1301-1315
45. Ghasemlou N, Lopez-Vales R, Lachance C, Thuraisingam T, Gaestel M, Radzioch D, and David S (2010) Mitogen-activated protein kinase-activated protein kinase 2 (MK2) contributes to secondary damage after spinal cord injury. J Neurosci 30: 13750-13759
46. Gibert B, Eckel B, Gonin V, Goldschneider D, Fombonne J, Deux B, Mehlen P, Arrigo AP, Clézardin P, and Diaz-Latoud C (2012) Targeting heat shock protein 27 (HspB1) interferes with bone metastasis and tumour formation in vivo. Br J Cancer 107:63-70
47. Golembieski WA, Thomas SL, Schultz CR, Yunker CK, McClung HM, Lemke N, Cazacu S, Barker T, Sage EH, and Brodie C et al. (2008) HSP27 mediates SPARCinduced changes in glioma morphology, migration, and invasion. Glia 56:1061-1075
48. Griffin WST, Liu L, Li Y, Mrak RE, and Barger SW (2006) Interleukin-1 mediates Alzheimer and Lewy body pathologies. J Neuroinflammation 3:5
49. Guan R, Tapang P, Leverson JD, Albert D, Giranda VL, and Luo Y (2005) Small interfering RNA-mediated Polo-like kinase 1 depletion preferentially reduces the survival of p53-defective, oncogenic transformed cells and inhibits tumor growth in animals. Cancer Res 65:2698-2704
50. Guertin AD, Li J, Liu Y, Hurd MS, Schuller AG, Long B, Hirsch HA, Feldman I, Benita Y, and Toniatti C et al. (2013) Preclinical evaluation of the WEE1 inhibitor MK-1775 as single-agent anticancer therapy. Mol Cancer Ther 12:1442-1452
51. Hannigan MO, Zhan L, Ai Y, Kotlyarov A, Gaestel M, and Huang C-K (2001) Abnormal migration phenotype of mitogen-activated protein kinase-activated protein kinase 22/2 neutrophils in Zigmond chambers containing formyl-methionyl-leucylphenylalanine gradients. J Immunol 167:3953-3961
52. Harper JW and Elledge SJ (2007) The DNA damage response: ten years after. Mol Cell 28:739-745
53. Hegen M, Gaestel M, Nickerson-Nutter CL, Lin LL, and Telliez JB (2006) MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritis. J Immunol 177: 1913-1917
54. Hillig RC, Eberspaecher U, Monteclaro F, Huber M, Nguyen D, Mengel A, Muller- Tiemann B, and Egner U (2007) Structural basis for a high affinity inhibitor bound to protein kinase MK2 J Mol Biol 369:735-745
55. Hirose Y, Berger MS, and Pieper RO (2001) Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells. Cancer Res 61:5843-5849
56. Hirose Y, Katayama M, Berger MS, and Pieper RO (2004) Cooperative function of Chk1 and p38 pathways in activating G2 arrest following exposure to temozolomide. J Neurosurg 100:1060-1065
57. Hirose Y, Katayama M, Stokoe D, Haas-Kogan DA, Berger MS, and Pieper RO (2003) The p38 mitogen-activated protein kinase pathway links the DNA mismatch repair system to the G2 checkpoint and to resistance to chemotherapeutic DNA-methylating agents. Mol Cell Biol 23:8306-8315
58. Hoeijmakers JH (2001) Genome maintenance mechanisms for preventing cancer. Nature 411:366-374
59. Hoffmann I, Draetta G, and Karsenti E (1994) Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J 13:4302-4310
60. Höpker K, Hagmann H, Khurshid S, Chen S, Hasskamp P, Seeger-Nukpezah T, Schilberg K, Heukamp L, Lamkemeyer T, and Sos ML et al. (2012) AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis. EMBO J 31:3961-3975
61. Huang L, Min J-N, Masters S, Mivechi NF, and Moskophidis D (2007) Insights into function and regulation of small heat shock protein 25 (HSPB1) in a mouse model with targeted gene disruption. Genesis 45:487-501
62. Huang X, Zhu X, Chen X, Zhou W, Xiao D, Degrado S, Aslanian R, Fossetta J, Lundell D, and Tian F et al. (2012) A three-step protocol for lead optimization: quick identification of key conformational features and functional groups in the SAR studies of non-ATP competitive MK2 (MAPKAPK2) inhibitors. Bioorg Med Chem Lett 22:65-70
63. Ischia J and So AI (2013) The role of heat shock proteins in bladder cancer. Nat Rev Urol 10:386-395
64. Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J, and Jackson SP (2006) ATM- and cell cycle-dependent regulation of ATR in response to DNA doublestrand breaks. Nat Cell Biol 8:37-45
65. Kaptein A, Oubrie A, de Zwart E, Hoogenboom N, de Wit J, van de Kar B, van Hoek M, Vogel G, de Kimpe V, and Schultz-Fademrecht C et al. (2011) Discovery of selective and orally available spiro-3-piperidyl ATP-competitive MK2 inhibitors. Bioorg Med Chem Lett 21:3823-3827
66. Kastan MB and Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432: 316-323
67. Kishi H, Nakagawa K, Matsumoto M, Suga M, Ando M, Taya Y, and Yamaizumi M (2001) Osmotic shock induces G1 arrest through p53 phosphorylation at Ser33 by activated p38MAPK without phosphorylation at Ser15 and Ser20 J Biol Chem 276:39115-39122
68. Kobayashi M, Nishita M, Mishima T, Ohashi K, and Mizuno K (2006) MAPKAPK-2- mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration. EMBO J 25:713-726
69. Kobayashi Y, Qi X, and Chen G (2012) MK2 regulates Ras oncogenesis through stimulating ROS production. Genes Cancer 3:521-530
70. Köpper F, Bierwirth C, Schön M, Kunze M, Elvers I, Kranz D, Saini P, Menon MB, Walter D, and Sørensen CS et al. (2013) Damage-induced DNA replication stalling relies on MAPK-activated protein kinase 2 activity. Proc Natl Acad Sci USA 110: 16856-16861
71. Kostenko S and Moens U (2009) Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell Mol Life Sci 66:3289-3307
72. Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk HD, and Gaestel M (1999) MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol 1:94-97
73. Kotlyarov A, Yannoni Y, Fritz S, Laass K, Telliez J-B, Pitman D, Lin L-L, and Gaestel M (2002) Distinct cellular functions of MK2 Mol Cell Biol 22:4827-4835
74. Kukkonen-Macchi A, Sicora O, Kaczynska K, Oetken-Lindholm C, Pouwels J, Laine L, and Kallio MJ (2011) Loss of p38g MAPK induces pleiotropic mitotic defects and massive cell death. J Cell Sci 124:216-227
75. Kumagai A, Kim SM, and Dunphy WG (2004) Claspin and the activated form of ATRATRIP collaborate in the activation of Chk1 J Biol Chem 279:49599-49608
76. Kumar B, Koul S, Petersen J, Khandrika L, Hwa JS, Meacham RB, Wilson S, and Koul HK (2010) p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity. Cancer Res 70:832-841
77. Lafarga V, Cuadrado A, Lopez de Silanes I, Bengoechea R, Fernandez-Capetillo O, and Nebreda AR (2009) p38 Mitogen-activated protein kinase- and HuR-dependent stabilization of p21(Cip1) mRNA mediates the G(1)/S checkpoint. Mol Cell Biol 29: 4341-4351
78. Lam MH, Liu Q, Elledge SJ, and Rosen JM (2004) Chk1 is haploinsufficient for multiple functions critical to tumor suppression. Cancer Cell 6:45-59
79. Lammer C, Wagerer S, Saffrich R, Mertens D, Ansorge W, and Hoffmann I (1998) The cdc25B phosphatase is essential for the G2/M phase transition in human cells. J Cell Sci 111:2445-2453
80. Lasa M, Mahtani KR, Finch A, Brewer G, Saklatvala J, and Clark AR (2000) Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol Cell Biol 20:4265-4274
81. Lemaire M, Froment C, Boutros R, Mondesert O, Nebreda AR, Monsarrat B, and Ducommun B (2006) CDC25B phosphorylation by p38 and MK-2 Cell Cycle 5: 1649-1653
82. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F, and Bradley A et al. (2000) Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev 14:1448-1459
83. Liu X and Erikson RL (2003) Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells. Proc Natl Acad Sci USA 100:5789-5794
84. Llopis A, Salvador N, Ercilla A, Guaita-Esteruelas S, Barrantes Idel B, Gupta J, Gaestel M, Davis RJ, Nebreda AR, and Agell N (2012) The stress-activated protein kinases p38a/b and JNK1/2 cooperate with Chk1 to inhibit mitotic entry upon DNA replication arrest. Cell Cycle 11:3627-3637
85. Manke IA, Nguyen A, Lim D, Stewart MQ, Elia AE, and Yaffe MB (2005) MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol Cell 17:37-48
86. Marotta D, Karar J, Jenkins WT, Kumanova M, Jenkins KW, Tobias JW, Baldwin D, Hatzigeorgiou A, Alexiou P, and Evans SM et al. (2011) In vivo profiling of hypoxic gene expression in gliomas using the hypoxia marker EF5 and laser-capture microdissection. Cancer Res 71:779-789
87. Matsuoka S, Huang M, and Elledge SJ (1998) Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282:1893-1897
88. McLaughlin MM, Kumar S, McDonnell PC, Van Horn S, Lee JC, Livi GP, and Young PR (1996) Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase. J Biol Chem 271:8488-8492
89. Mikhailov A, Shinohara M, and Rieder CL (2004) Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway. J Cell Biol 166:517-526
90. Mikhailov A, Shinohara M, and Rieder CL (2005) The p38-mediated stress-activated checkpoint. A rapid response system for delaying progression through antephase and entry into mitosis. Cell Cycle 4:57-62
91. Mir SE, De Witt Hamer PC, Krawczyk PM, Balaj L, Claes A, Niers JM, Van Tilborg AAG, Zwinderman AH, Geerts D, and Kaspers GJL et al. (2010) In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma. Cancer Cell 18:244-257
92. Miyata Y, Watanabe S-i, Sagara Y, Mitsunari K, Matsuo T, Ohba K, and Sakai H (2013) High expression of HuR in cytoplasm, but not nuclei, is associated with malignant aggressiveness and prognosis in bladder cancer. PLoS ONE 8:e59095
93. Mourey RJ, Burnette BL, Brustkern SJ, Daniels JS, Hirsch JL, Hood WF, Meyers MJ, Mnich SJ, Pierce BS, and Saabye MJ et al. (2010) A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor a production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation. J Pharmacol Exp Ther 333:797-807
94. Nomura N, Nomura M, Sugiyama K, and Hamada J-I (2007) Phorbol 12-myristate 13-acetate (PMA)-induced migration of glioblastoma cells is mediated via p38MAPK/ Hsp27 pathway. Biochem Pharmacol 74:690-701
95. Oubrie A, Kaptein A, de Zwart E, Hoogenboom N, Goorden R, van de Kar B, van Hoek M, de Kimpe V, van der Heijden R, and Borsboom J et al. (2012) Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series. Bioorg Med Chem Lett 22:613-618
96. Patil M, Pabla N, and Dong Z (2013) Checkpoint kinase 1 in DNA damage response and cell cycle regulation. Cell Mol Life Sci 70:4009-4021
97. Pedraza-Alva G, Koulnis M, Charland C, Thornton T, Clements JL, Schlissel MS, and Rincón M (2006) Activation of p38 MAP kinase by DNA double-strand breaks in V(D)J recombination induces a G2/M cell cycle checkpoint. EMBO J 25:763-773
98. Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, and Piwnica-Worms H (1997) Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216 Science 277:1501-1505
99. Phong MS, Van Horn RD, Li S, Tucker-Kellogg G, Surana U, and Ye XS (2010) p38 mitogen-activated protein kinase promotes cell survival in response to DNA damage but is not required for the G(2) DNA damage checkpoint in human cancer cells. Mol Cell Biol 30:3816-3826
100. Plath K, Engel K, Schwedersky G, and GaestelM(1994) Characterization of the prolinerich region of mouse MAPKAP kinase 2: influence on catalytic properties and binding to the c-abl SH3 domain in vitro. Biochem Biophys Res Commun 203:1188-1194
101. Qin J, Dhondi P, Huang X, Aslanian R, Fossetta J, Tian F, Lundell D, and Palani A (2011) Discovery of a potent dihydrooxadiazole series of non-ATP-competitive MK2 (MAPKAPK2) inhibitors. ACS Med Chem Lett 3:100-105 DOI: 10.1021/ml200238g. Reagan-Shaw S and
102. Ahmad N (2005) Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer. FASEB J 19:611-613
103. Reinhardt HC, Aslanian AS, Lees JA, and Yaffe MB (2007) p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell 11:175-189
104. Reinhardt HC, Hasskamp P, Schmedding I, Morandell S, van Vugt MA, Wang X, Linding R, Ong SE, Weaver D, and Carr SA et al. (2010) DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization. Mol Cell 40:34-49
105. Reinhardt HC and Yaffe MB (2009) Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2 Curr Opin Cell Biol 21:245-255
106. Ronkina N, Kotlyarov A, Dittrich-Breiholz O, Kracht M, Hitti E, Milarski K, Askew R, Marusic S, Lin L-L, and Gaestel M et al. (2007) The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK. Mol Cell Biol 27:170-181
107. Ronkina N, Kotlyarov A, and Gaestel M (2008) MK2 and MK3-A pair of isoenzymes? Front Biosci 13:5511-5521
108. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, and Linn S (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73:39-85
109. Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H, and Elledge SJ (1997) Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25 Science 277:1497-1501
110. Sandler H and Stoecklin G (2008) Control of mRNA decay by phosphorylation of tristetraprolin. Biochem Soc Trans 36:491-496
111. Sarcar B, Kahali S, Prabhu AH, Shumway SD, Xu Y, Demuth T, and Chinnaiyan P (2011) Targeting radiation-induced G(2) checkpoint activation with the Wee-1 inhibitor MK-1775 in glioblastoma cell lines. Mol Cancer Ther 10:2405-2414
112. Schlapbach A and Huppertz C (2009) Low-molecular-weight MK2 inhibitors: a tough nut to crack! Future Med Chem 1:1243-1257
113. Schultz CR, Golembieski WA, King DA, Brown SL, Brodie C, and Rempel SA (2012) Inhibition of HSP27 alone or in combination with pAKT inhibition as therapeutic approaches to target SPARC-induced glioma cell survival. Mol Cancer 11:20
114. Schwarz JK, Lovly CM, and Piwnica-Worms H (2003) Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation. Mol Cancer Res 1:598-609
115. Shiloh Y (2003) ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3:155-168
116. Shiota M, Bishop JL, Nip KM, Zardan A, Takeuchi A, Cordonnier T, Beraldi E, Bazov J, Fazli L, and Chi K et al. (2013) Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer. Cancer Res 73: 3109-3119
117. Sithanandam G, Latif F, Duh FM, Bernal R, Smola U, Li H, Kuzmin I, Wixler V, Geil L, and Shrestha S (1996) 3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region. Mol Cell Biol 16:868-876
118. Stetler RA, Cao G, Gao Y, Zhang F, Wang S, Weng Z, Vosler P, Zhang L, Signore A, and Graham SH et al. (2008) Hsp27 protects against ischemic brain injury via attenuation of a novel stress-response cascade upstream of mitochondrial cell death signaling. J Neurosci 28:13038-13055
119. Stetler RA, Gao Y, Zhang L, Weng Z, Zhang F, Hu X, Wang S, Vosler P, Cao G, and Sun D et al. (2012) Phosphorylation of HSP27 by protein kinase D is essential for mediating neuroprotection against ischemic neuronal injury. J Neurosci 32: 2667-2682
120. Stoecklin G, Stubbs T, Kedersha N, Wax S, Rigby WF, Blackwell TK, and Anderson P (2004) MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J 23:1313-1324
121. Stokoe D, Campbell DG, Nakielny S, Hidaka H, Leevers SJ, Marshall C, and Cohen P (1992) MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase. EMBO J 11:3985-3994
122. Straume O, Shimamura T, Lampa MJG, Carretero J, Oyan AM, Jia D, Borgman CL, Soucheray M, Downing SR, and Short SM et al. (2012) Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer. Proc Natl Acad Sci USA 109:8699-8704
123. Strebhardt K (2010) Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nat Rev Drug Discov 9:643-660
124. Suswam E, Li Y, Zhang X, Gillespie GY, Li X, Shacka JJ, Lu L, Zheng L, and King PH (2008) Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells. Cancer Res 68:674-682
125. Swinney DC (2004) Biochemical mechanisms of drug action: what does it take for success? Nat Rev Drug Discov 3:801-808
126. Swinney DC and Anthony J (2011) How were new medicines discovered? Nat Rev Drug Discov 10:507-519
127. Takai H, Tominaga K, Motoyama N, Minamishima YA, Nagahama H, Tsukiyama T, Ikeda K, Nakayama K, Nakanishi M, and Nakayama K (2000) Aberrant cell cycle checkpoint function and early embryonic death in Chk12/2 mice. Genes Dev 14: 1439-1447
128. Takekawa M, Adachi M, Nakahata A, Nakayama I, Itoh F, Tsukuda H, Taya Y, and Imai K (2000) p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J 19: 6517-6526
129. Tanabe K, Matsushima-Nishiwaki R, Dohi S, and Kozawa O (2010) Phosphorylation status of heat shock protein 27 regulates the interleukin-1b-induced interleukin-6 synthesis in C6 glioma cells. Neuroscience 170:1028-1034
130. Tandle AT, Kramp T, Kil WJ, Halthore A, Gehlhaus K, Shankavaram U, Tofilon PJ, Caplen NJ, and Camphausen K (2013) Inhibition of polo-like kinase 1 in glioblastoma multiforme induces mitotic catastrophe and enhances radiosensitisation. Eur J Cancer 49:3020-3028
131. Tang J, Yang X, and Liu X (2008) Phosphorylation of Plk1 at Ser326 regulates its functions during mitotic progression. Oncogene 27:6635-6645
132. Thomas T, Hitti E, Kotlyarov A, Potschka H, and Gaestel M (2008a) MAP-kinaseactivated protein kinase 2 expression and activity is induced after neuronal depolarization. Eur J Neurosci 28:642-654
133. Thomas T, Timmer M, Cesnulevicius K, Hitti E, Kotlyarov A, and Gaestel M (2008b) MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation-relevance in a mouse model of Parkinson's disease. J Neurochem 105:2039-2052
134. Tiedje C, Ronkina N, Tehrani M, Dhamija S, Laass K, Holtmann H, Kotlyarov A, and Gaestel M (2012) The p38/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation. PLoS Genet 8:e1002977
135. Trempolec N, Dave-Coll N, and Nebreda AR (2013) SnapShot: p38 MAPK substrates. Cell 152:924-924.e1 DOI: 10.1016/j.cell.2013.01.047
136. Vician LJ, Xu G, Liu W, Feldman JD, Machado HB, and Herschman HR (2004) MAPKAP kinase-2 is a primary response gene induced by depolarization in PC12 cells and in brain. J Neurosci Res 78:315-328
137. Vogelstein B, Lane D, and Levine AJ (2000) Surfing the p53 network. Nature 408: 307-310
138. Vousden KH and Lu X (2002) Live or let die: the cell's response to p53 Nat Rev Cancer 2:594-604
139. Wang X, Xu L, Wang H, Young PR, Gaestel M, and Feuerstein GZ (2002) Mitogenactivated protein kinase-activated protein (MAPKAP) kinase 2 deficiency protects brain from ischemic injury in mice. J Biol Chem 277:43968-43972
140. Watterson DM, Grum-Tokars VL, Roy SM, Schavocky JP, Bradaric BD, Bachstetter AD, Xing B, Dimayuga E, Saeed F, and Zhang H et al. (2013) Development of novel in vivo chemical probes to address CNS protein kinase involvement in synaptic dysfunction. PLoS ONE 8:e66226
141. Weber HO, Ludwig RL, Morrison D, Kotlyarov A, Gaestel M, and Vousden KH (2005) HDM2 phosphorylation by MAPKAP kinase 2 Oncogene 24:1965-1972
142. Xiao Z, Xue J, Sowin TJ, and Zhang H (2006) Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy. Mol Cancer Ther 5:1935-1943
143. Xu L, Chen S, and Bergan RC (2006) MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer. Oncogene 25:2987-2998
144. Zhang R, Tremblay T-L, McDermid A, Thibault P, and Stanimirovic D (2003) Identification of differentially expressed proteins in human glioblastoma cell lines and tumors. Glia 42:194-208.
145. Zhu Z, Xu X, Yu Y, Graham M, Prince ME, Carey TE, and Sun D (2010) Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous cell cancer cells in vitro. Mol Pharm 7:1283-1290.